Role of Tight Glycemic Control during Acute Coronary Syndrome on CV Outcome in Type 2 Diabetes

The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)–TIMI 58 Trial

(2018) Stephen D. Wiviott et al.   AMERICAN HEART JOURNAL

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

(2017) Borja Ibanez et al.   EUROPEAN HEART JOURNAL

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

(2017) Bruce Neal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

(2017) Olga Vaccaro et al.   Lancet Diabetes & Endocrinology

In-hospital free fatty acids levels predict the severity of myocardial ischemia of acute coronary syndrome

(2016) Pei Ma et al.   BMC Cardiovascular Disorders

Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes: Table 1

(2016)   DIABETES CARE

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

(2016) Steven P. Marso et al.   NEW ENGLAND JOURNAL OF MEDICINE

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

(2015) Bernard Zinman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

(2015) Jennifer B. Green et al.   NEW ENGLAND JOURNAL OF MEDICINE

Correlation of Plasma Catestatin Level and the Prognosis of Patients with Acute Myocardial Infarction

(2015) Dan Zhu et al.   PLoS One

Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial

(2014) Viveca Ritsinger et al.   Lancet Diabetes & Endocrinology

Coronary Artery Revascularization in Patients With Diabetes Mellitus

(2013) Ehrin J. Armstrong et al.   CIRCULATION

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

(2013)   EUROPEAN HEART JOURNAL

Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

(2013) William B. White et al.   NEW ENGLAND JOURNAL OF MEDICINE

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

(2013) Benjamin M. Scirica et al.   NEW ENGLAND JOURNAL OF MEDICINE

Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes

(2012) Jun Panee   CYTOKINE

Association between DNA strand breakage and oxidative, inflammatory and endothelial biomarkers in type 2 diabetes

(2012) Etiane Tatsch et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

Prognostic Value of Admission Glycosylated Hemoglobin and Glucose in Nondiabetic Patients With ST-Segment–Elevation Myocardial Infarction Treated With Percutaneous Coronary Intervention

(2011) Jorik R. Timmer et al.   CIRCULATION

The effect of intensive risk factor management in type 2 diabetes on inflammatory biomarkers

(2011) Xanthia F. Samaropoulos et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Tight Glycemic Control May Increase Regenerative Potential of Myocardium during Acute Infarction

(2011) Raffaele Marfella et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Chronic exposure to high fatty acids impedes receptor agonist-induced nitric oxide production and increments of cytosolic Ca2+ levels in endothelial cells

(2011) Yanxia Tang et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Relationship of methylglyoxal-adduct biogenesis to LDL and triglyceride levels in diabetics

(2011) Zdenka Turk et al.   LIFE SCIENCES

Epigenetics

(2010) Mark E. Cooper et al.   CIRCULATION RESEARCH

Comparison of glucose-insulin-potassium and insulin-glucose as adjunctive therapy in acute myocardial infarction: a contemporary meta-analysis of randomised controlled trials

(2010) Y.-T. Zhao et al.   HEART

Control of free fatty acids during acute myocardial ischaemia

(2010) M. F. Oliver   HEART

Free fatty acids induce endothelial dysfunction and activate protein kinase C and nuclear factor-κB pathway in rat aorta

(2010) Hua Li et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Intensive versus Conventional Glucose Control in Critically Ill Patients

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Prevention of cardiovascular disease through glycemic control in type 2 diabetes: A meta-analysis of randomized clinical trials

(2009) E. Mannucci et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk

(2008) Tina Ken Schramm et al.   CIRCULATION

Hyperglycemia and Acute Coronary Syndrome

(2008) Prakash Deedwania et al.   CIRCULATION

Free fatty acids as a cardiovascular risk factor

(2008) Stefan Pilz et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Intensive Glucose Lowering in Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis

(2008) Frank M. Brunkhorst et al.   NEW ENGLAND JOURNAL OF MEDICINE

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes

(2008) William Duckworth et al.   NEW ENGLAND JOURNAL OF MEDICINE